The FDA has approved a number of peptides as medications, including insulin for diabetics who dont naturally produce it and human growth hormone for children with developmental disorders caused by low levels of the hormone
Absence of COA documentation or reluctance to provide testing results raises immediate concerns
The Lancet (2023) This Phase 2 trial evaluated CagriSema versus semaglutide alone and cagrilintide alone in 92 adults with type 2 diabetes and overweight or obesity on metformin with or without an SGLT2 inhibitor across 17 US sites
Patients should avoid assuming that a research finding automatically translates into a personal treatment plan
results may be slower than injections Injectable Peptides Best for: BPC-157, TB-500, GHK-Cu (subcutaneous) Advantages: Higher bioavailability, systemic benefits beyond hair (skin, joints, healing), faster onset of action Limitations: Requires injection protocol, not suitable for everyone, may need to be administered by a healthcare professional The Combination Approach Many practitioners and biohackers report the best results by combining topical and injectable peptides